Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non–Small-Cell Lung Cancer and High PD-L1 Tumor Expression

Authors:

Abstract
No abstract available

This publication has 23 references indexed in Scilit: